159 related articles for article (PubMed ID: 37165255)
1. ZNRF2 as an oncogene is transcriptionally regulated by CREB1 in breast cancer models.
Liu JT; Sun ZX; Zhong R; Zhang YD; Wang T; Hou YD; Bao JH; Zhang L; Chen B
Hum Cell; 2023 Jul; 36(4):1501-1515. PubMed ID: 37165255
[TBL] [Abstract][Full Text] [Related]
2. LINC01857 as an oncogene regulates CREB1 activation by interacting with CREBBP in breast cancer.
Xiong Y; Gu Y; Wang F; Li L; Zhu M; Wang N; Mi H; Qiu X
J Cell Physiol; 2019 Aug; 234(8):14031-14039. PubMed ID: 30628071
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of CREB1 inhibits tumor growth of human gastric cancer in vitro and in vivo.
Rao M; Zhu Y; Cong X; Li Q
Oncol Rep; 2017 Jun; 37(6):3361-3368. PubMed ID: 28498439
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1.
Lv M; Mao Q; Li J; Qiao J; Chen X; Luo S
Cell Mol Biol Lett; 2020; 25():43. PubMed ID: 32983239
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic cAMP responsive element binding protein 1 is overexpressed upon loss of tumor suppressive miR-10b-5p and miR-363-3p in renal cancer.
Li Y; Chen D; Li Y; Jin L; Liu J; Su Z; Qi Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Mao X; Chen Y; Lai Y
Oncol Rep; 2016 Apr; 35(4):1967-78. PubMed ID: 26796749
[TBL] [Abstract][Full Text] [Related]
7. miR-450a exerts oncosuppressive effects in breast carcinoma by targeting CREB1.
Zhang Y; Han XX; Lin XM; Li Z; Zhang JH
Kaohsiung J Med Sci; 2022 Jul; 38(7):643-652. PubMed ID: 35451558
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1.
Dong H; Cao W; Xue J
Biochem Biophys Res Commun; 2019 Jan; 508(4):1074-1081. PubMed ID: 30553445
[TBL] [Abstract][Full Text] [Related]
9. IGF2-AS knockdown inhibits glycolysis and accelerates apoptosis of gastric cancer cells through targeting miR-195/CREB1 axis.
Yan B; Ren Z; Sun J; Ding C; Yang D
Biomed Pharmacother; 2020 Oct; 130():110600. PubMed ID: 34321174
[TBL] [Abstract][Full Text] [Related]
10. CKAP2L, transcriptionally inhibited by FOXP3, promotes breast carcinogenesis through the AKT/mTOR pathway.
Chi F; Chen L; Jin X; He G; Liu Z; Han S
Exp Cell Res; 2022 Mar; 412(2):113035. PubMed ID: 35065924
[TBL] [Abstract][Full Text] [Related]
11. SEZ6L2, regulated by USF1, accelerates the growth and metastasis of breast cancer.
Chen L; Han S; Li Y; Zheng Y; Zhang Q
Exp Cell Res; 2022 Aug; 417(1):113194. PubMed ID: 35523305
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑188‑5p inhibits the progression of breast cancer by targeting zinc finger protein 91.
Yang Z; Liu Z; Chang Z; Yan G
Oncol Rep; 2020 Oct; 44(4):1479-1488. PubMed ID: 32945499
[TBL] [Abstract][Full Text] [Related]
13. Effects of cisplatin on the proliferation, invasion and apoptosis of breast cancer cells following β‑catenin silencing.
Zhu X; Feng J; Fu W; Shu X; Wan X; Liu J
Int J Mol Med; 2020 Jun; 45(6):1838-1850. PubMed ID: 32186756
[TBL] [Abstract][Full Text] [Related]
14. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
15. Long noncoding RNA DQ786243 interacts with miR-506 and promotes progression of ovarian cancer through targeting cAMP responsive element binding protein 1.
Yan H; Silva MA; Li H; Zhu L; Li P; Li X; Wang X; Gao J; Wang P; Zhang Z
J Cell Biochem; 2018 Dec; 119(12):9764-9780. PubMed ID: 30105876
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑138 modulates glioma cell growth, apoptosis and invasion through the suppression of the AKT/mTOR signalling pathway by targeting CREB1.
Zhang C; Wang Q; Zhou X; Zhang L; Yao Y; Gu J; Chen H; Qian J; Luo C; Bai Q; Hu G
Oncol Rep; 2020 Dec; 44(6):2559-2568. PubMed ID: 33125147
[TBL] [Abstract][Full Text] [Related]
17. Demethylation of miR-495 inhibits cell proliferation, migration and promotes apoptosis by targeting STAT-3 in breast cancer.
Chen Y; Luo D; Tian W; Li Z; Zhang X
Oncol Rep; 2017 Jun; 37(6):3581-3589. PubMed ID: 28498478
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA LINC01287 promotes breast cancer cells proliferation and metastasis by activating Wnt/ß-catenin signaling.
Song C; Sun P; He Q; Liu LL; Cui J; Sun LM
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4234-4242. PubMed ID: 31173295
[TBL] [Abstract][Full Text] [Related]
19. The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma.
Li CF; Wu WJ; Wu WR; Liao YJ; Chen LR; Huang CN; Li CC; Li WM; Huang HY; Chen YL; Liang SS; Chow NH; Shiue YL
Oncotarget; 2015 Apr; 6(11):9220-39. PubMed ID: 25940704
[TBL] [Abstract][Full Text] [Related]
20. Silencing of circ_0007299 suppresses proliferation, migration, and invasiveness and promotes apoptosis of ectopic endometrial stromal cells in endometriosis via miR-424-5p-dependent modulation of CREB1.
Mao H; Zhang X; Yin L; Ji X; Huang C; Wu Q
Arch Gynecol Obstet; 2023 Jan; 307(1):149-161. PubMed ID: 35708784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
